Big Pharma's $300 Billion Patent Problem Fuels Biotech Deals
Biotech ETF Index Surges 10% After Rebalance
Apogee Therapeutics, Definium Therapeutics, Baldwin Insurance And Other Big Stocks Moving Higher On Monday
Crude Oil Falls Over 2%; Getty Images Shares Spike Higher
AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash
Apogee Therapeutics Stock Soars. It's Being Bought by AbbVie for $10.9 Billion.
AbbVie strikes $10.9 billion deal for Apogee Therapeutics
Intel, Micron, SpaceX, Apogee Therapeutics, and More Stocks That Explain Today's Market
AbbVie nears $11 billion deal for Apogee Therapeutics, FT reports